Search the Newsreel

The Joint Corp (NASDAQ: JYNT) earns $1.95M as it refranchises clinics

The Joint Corp reported higher profitability for the six months ended June 30, 2026, with total net income of $1.95 million and diluted EPS of $0.14, driven by its ongoing shift to a franchise-focused model. The company's continuing operations generated $30.0 million in revenue, …

The Joint Corp earnings beat by $0.02, revenue topped estimates

The Joint Corp (NASDAQ: JYNT) reported strong second-quarter results, surpassing analyst expectations with an EPS of $0.05 against an estimated $0.03. The company also exceeded revenue forecasts, bringing in $15.2M compared to the $14.57M consensus. Despite these positive earnings, the stock has seen declines …

Earnings call transcript: The Joint tops Q2 2026 estimates as profit improves

The Joint Corp. exceeded Q2 2026 earnings and revenue estimates, reporting adjusted EPS of $0.05 and revenue of $15.2 million, driven by its shift towards a capital-light franchising model. The company saw a significant improvement in profitability, with adjusted EBITDA from continuing operations rising …

The Joint Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:JYNT) 2026-08-06

The Joint Corp (JYNT) (Q2 2026) Earnings Call Highlights: Refranchising Nears Completion, ...

The Joint Corp (JYNT) reported a 14% year-over-year revenue increase to $15.2 million in Q2 2026, driven by its shift to a pure-play franchisor model, and its refranchising initiative is nearing completion. Despite these positive financial indicators, system-wide sales declined by 3.7%, and the …

The Joint Corp. (NASDAQ: JYNT) boosts Q2 profit and keeps 2026 targets

The Joint Corp. reported strong Q2 2026 results, with revenue up 14% to $15.2 million and consolidated net income reaching $653,000, reflecting its transition to a capital-light franchisor model. Despite a 3.7% decrease in system-wide sales and negative comparable sales, the company improved Adjusted …

The Joint Corp. Reports Second Quarter 2026 Financial Results

The Joint Corp. (NASDAQ: JYNT) reported its financial results for the second quarter ended June 30, 2026, showcasing significant improvements in consolidated net income, adjusted EBITDA from continuing operations, and cash flow from operating activities. The company's revenues grew 14% to $15.2 million, and …

The Joint Corp. Posts $1.9M Free Cash Flow Under Pure-Play Model

The Joint Corp. reported strong Q2 2026 financial results, with revenue up 14% to $15.2 million and consolidated net income increasing significantly. The company also achieved $1.9 million in free cash flow and substantially completed its refranchising initiative, transitioning to a capital-light, pure-play franchisor …

Joint Number of Employees 2026 | Employee Count & Headcount Data

The Joint Corp. (JYNT) had approximately 337 employees worldwide as of March 2026, a 10.0% decline from 2023. Despite this, the company is actively hiring, with 1,053 active job postings in 2026, a 22.5% increase from 2025. The majority of its workforce is in …

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

Why (JYNT) Price Action Is Critical for Tactical Trading

This article analyzes The Joint Corp. (NASDAQ: JYNT) with a focus on its price action for tactical trading. It highlights a near-term neutral sentiment suggesting a pause in mid and long-term weakness, identifying an exceptional short setup with a 55.0:1 risk-reward ratio. The analysis …

The Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise Investment

The Joint Corp. (NASDAQ: JYNT), franchisor of The Joint Chiropractic, has been honored by Entrepreneur as one of its Top Brands for Multi-Unit Owners for 2026. This recognition highlights the brand's scalable, low-labor, retail healthcare model, making it an attractive investment for multi-unit operators. …

Joint Corp (JYNT) Institutional Confidence

Joint Corp (JYNT)'s institutional shareholding score is 7.00, placing it 37th out of 75 in the Healthcare Providers & Services industry. The institutional shareholding proportion has increased to 84.56%, representing an 8.26% quarter-over-quarter rise. James Simons is the largest institutional shareholder, holding 1.60% of …

Joint (JYNT) to Post Quarterly Earnings on Thursday

Joint Corp (JYNT) Financial Health: Profitability & Balance Sheet Analysis

TradingKey's analysis of Joint Corp (JYNT) shows a robust financial score of 7.70, ranking it 36th in the Healthcare Providers & Services industry. The company reported a 13.33% year-over-year revenue increase to $14.82M and a 62.10% increase in net profit. While its financial status …

BlackRock (JYNT holder) discloses 1.9% beneficial stake in JOINT Corp

BlackRock, Inc. has filed a Schedule 13G/A, disclosing a beneficial ownership of 267,616 shares (1.9%) of JOINT Corp's common stock as of June 30, 2026. BlackRock maintains sole voting and dispositive power over these shares, with various underlying clients having rights to dividends or …

Joint Corp (JYNT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Joint Corp (JYNT), highlighting its current valuation score, P/E ratio, and industry ranking. As of July 27, 2026, the company's valuation score is 4.56, placing it 70th out of 75 in the Healthcare Providers & Services industry, …

The Joint Corp. Revenue Breakdown – NASDAQ:JYNT

The Joint Corp. (NASDAQ: JYNT) generated $54.90 million USD in revenue last year. The "Royalty Fees" segment was the top-performing segment, contributing $33.20 million USD, an increase from $32.14 million USD in the previous year. All of the company's revenue last year came from …

Joint Corp (JYNT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Joint Corp (JYNT)'s dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. Key financial data like market cap and P/E ratio are included, along with current stock …

JYNT|Joint Corp|Price:8.650|Chg%:+0.300

Joint Corp's fundamentals are strong with high growth potential, and its valuation is considered fair. Analysts rate it as a Hold with a target price of $10.00, suggesting stability in the medium term. The company, which franchises and operates chiropractic clinics, has shown consistent …

The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast

The Joint Corp. announced it will report its 2026 second quarter financial results on Thursday, August 6, 2026, after market close. The company will also host a conference call and webcast at 5:00 p.m. ET on the same day, featuring President and CEO Sanjiv …

The Joint Chiropractic to discuss results across 950-plus locations

The Joint Corp. (NASDAQ: JYNT) announced it will report its Q2 2026 financial results after

Understanding Momentum Shifts in (JYNT)

The Joint Corp. (JYNT) is showing near-term weak sentiment that may lead to a resumption of long-term weakness, despite a neutral shift. AI models have developed three trading strategies—Position, Momentum Breakout, and Risk Hedging—to capitalize on potential shifts with optimized risk management. The analysis …

JYNT Q1 2026 Earnings: Massive EPS Beat Sparks Rally - Performance Review

Earnings call transcript: The Joint Corp. beats Q1 2026 EPS forecast, stock dips

What date does The Joint's (JYNT) report Earnings - Earnings Calendar & Announcement

Joint (JYNT) Earnings Date and Reports 2026 $JYNT

The Joint Corp. (JYNT) stock price, news, quote and history